{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T13:29:49Z","timestamp":1698499789193},"reference-count":76,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":6878,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1996,11]]},"DOI":"10.1111\/j.1600-0404.1996.tb07075.x","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T21:38:07Z","timestamp":1233265087000},"page":"329-336","source":"Crossref","is-referenced-by-count":13,"title":["Clozapine for the treatment of psychosis in Parkinson's disease: a review"],"prefix":"10.1155","volume":"94","author":[{"given":"P.","family":"Auzou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"\u00d6zsancak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hannequin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mds.870070205","article-title":"Clozapine prevents recurrence of psychosis in Parkinson's disease","volume":"7","author":"Factor","year":"1992","journal-title":"Mov Disord"},{"issue":"Suppl. 6","key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB2","first-page":"S47","article-title":"Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease","volume":"43","author":"Saint-Cyr","year":"1993","journal-title":"Neurology"},{"issue":"suppl","key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB3","first-page":"115","article-title":"Mental disorders in Parkinson's Disease","volume":"38","author":"Danielczyk","year":"1992","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB4","first-page":"259","article-title":"Mental disorders in Parkinson's disease after treatment with L-dopa","volume":"40","author":"Rondot","year":"1984","journal-title":"Adv Neurol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB5","first-page":"S104","volume-title":"Das Parkinsonsyndrom","author":"Ludin"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB6","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1212\/WNL.40.10.1513","article-title":"An estimate of the incidence of dementia in idiopathic Parkinson's disease","volume":"40","author":"Mayeux","year":"1990","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1212\/WNL.22.5.516","article-title":"Effects of levodopa in parkinsonian patients with dementia","volume":"22","author":"Sacks","year":"1972","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1532-5415.1991.tb03627.x","article-title":"Behavioral complications of drug treatments of Parkinson's disease","volume":"39","author":"Cummings","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB9","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/WNL.43.9.1690","article-title":"Antecedent clinical features associated with dementia in Parkinson's disease","volume":"43","author":"Stern","year":"1993","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB10","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1212\/WNL.33.11.1518","article-title":"L-Dopa long-term treatment in Parkinson's disease: age-related side-effects","volume":"33","author":"Pederzoli","year":"1983","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1212\/WNL.31.6.675","article-title":"Treatment of advanced Parkinson's disease with pergolide","volume":"31","author":"Lieberman","year":"1981","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.34.2.201","article-title":"Pergolide therapy for Parkinson's disease: Neurobehavioral changes","volume":"34","author":"Stern","year":"1984","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/jnnp.45.12.1161","article-title":"Confusion, dementia and anticholinergics in Parkinson's Disease","volume":"45","author":"Smet","year":"1982","journal-title":"J Neurol Neurosurg Psych"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB14","first-page":"703","article-title":"Treatment of drug-induced psychosis in Parkinson's disease with clozapine","volume":"60","author":"Greene","year":"1993","journal-title":"Adv Neurol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00002826-199108000-00001","article-title":"The management of the levodopa psychoses","volume":"14","author":"Friedman","year":"1991","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF00380972","article-title":"Treatment of drug-induced exogenous psychosis in Parkinsonism with clozapine and fluper-lapine","volume":"235","author":"Scholz","year":"1985","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1988.01800250087012","article-title":"Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs","volume":"45","author":"Farde","year":"1988","journal-title":"Arch Gen Psychiary"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0006-3223(88)90048-0","article-title":"Serial [18F]N-methylspiperone PET studies to measure changes in antipsychotic drug D2 receptor occupancy in schizophrenic patients","volume":"23","author":"Smith","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00589893","article-title":"Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactine levels","volume":"99","author":"Baron","year":"1989","journal-title":"Psychopharmacology"},{"issue":"Suppl. 17","key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1192\/S000712500029689X","article-title":"Clozapine and D1\/D2 antagonism in extrapyramidal functions","volume":"160","author":"Gerlach","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with neuroleptics and clozapine","volume":"49","author":"Farde","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/350610a0","article-title":"Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine","volume":"350","author":"Tol","year":"1991","journal-title":"Nature"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/358149a0","article-title":"Multiple dopamine D4 receptor variants in the human population","volume":"358","author":"Tol","year":"1992","journal-title":"Nature"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003495-199651010-00002","article-title":"The importance of dopamine D4 receptors in the action and development of antipsychotic agents","volume":"51","author":"Reynolds","year":"1996","journal-title":"Drugs"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(90)94100-C","article-title":"Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites","volume":"191","author":"Canton","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","article-title":"Clozapine: A novel antipsychotic agent","volume":"324","author":"Baldessarini","year":"1991","journal-title":"N Engl J Med"},{"issue":"Suppl. 17","key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/S0007125000296840","article-title":"General pharmacology of clozapine","volume":"160","author":"Coward","year":"1992","journal-title":"Br J Psychiatry"},{"issue":"Suppl. 17","key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1192\/S0007125000296876","article-title":"The importance of serotonin-dopamine interactions in the action of clozapine","volume":"160","author":"Meltzer","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0014-2999(92)90731-I","article-title":"Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue","volume":"221","author":"Mason","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB30","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.39.9.1219","article-title":"Clozapine in the treatment of psychosis in Parkinson's disease","volume":"39","author":"Friedman","year":"1989","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/mds.870050310","article-title":"Clozapine for psychosis in Parkinson's disease","volume":"5","author":"Pfeiffer","year":"1990","journal-title":"Mov Disord"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB32","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(94)92306-X","article-title":"Worsening of psychotic symptoms by clozapine in Parkinson's disease","volume":"344","author":"Auzou","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1212\/WNL.44.3_Part_1.544","article-title":"Clozapine: A 2-year open trial in Parkinson's disease patients with psychosis","volume":"44","author":"Factor","year":"1994","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB34","first-page":"100","article-title":"Clozapine in Parkinson's disease: three years experience","volume":"7","author":"Linazasoro","year":"1992","journal-title":"Mov Disord"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02251204","article-title":"Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinson's disease","volume":"5","author":"Pinter","year":"1993","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB36","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1212\/WNL.40.5.832","article-title":"Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis","volume":"40","author":"Wolters","year":"1990","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB37","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.41.10.1699","article-title":"Clozapine is beneficial for psychosis in Parkinson's disease","volume":"41","author":"Kahn","year":"1991","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB38","first-page":"39","article-title":"Plasma clozapine levels and the treatment of L-Dopa-induced psychosis in Parkinson's disease. A high potency effect of clozapine","volume":"12","author":"Meltzer","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB39","first-page":"251","article-title":"La clozapine dans le traitement des manifestations psychiatriques de la maladie de Parkinson","volume":"151","author":"Diederich","year":"1995","journal-title":"Rev Neurol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1176\/jnp.1.2.190","article-title":"Clozapine treatment of psychosis in Parkinson's disease","volume":"1","author":"Roberts","year":"1989","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB41","first-page":"373","article-title":"Clozapine treatment of psychosis in Parkinson's disease: A report of five consecutive cases","volume":"53","author":"Wolk","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB42","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(95)91001-8","article-title":"Clozapine therapeutic plunge in patient with Parkinson's disease","volume":"345","author":"Greene","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1532-5415.1993.tb06743.x","article-title":"Clozapine treatment of parkinsonism with psychosis","volume":"41","author":"Lew","year":"1993","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB44","first-page":"521","volume-title":"Therapy of Parkinson's disease","author":"Friedman","year":"1995"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0163-8343(92)90100-O","article-title":"Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease","volume":"14","author":"Rosenthal","year":"1992","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1445-5994.1994.tb01772.x","article-title":"The use of clozapine in Parkinson's disease","volume":"24","author":"Gonski","year":"1994","journal-title":"Aust NZ J Med"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB47","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1212\/WNL.40.7.1151","article-title":"Clozapine in idiopathic Parkinson's disease","volume":"40","author":"Bernardi","year":"1990","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1600-0404.1986.tb03279.x","article-title":"Clozapine in the treatment of tremor","volume":"73","author":"Pakkenberg","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mds.870050307","article-title":"Clozapine-responsive tremor in Parkinson's disease","volume":"5","author":"Friedman","year":"1990","journal-title":"Mov Disord"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF02257654","article-title":"Treatment of parkinsonian tremor with clozapine","volume":"2","author":"Fischer","year":"1990","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB51","first-page":"277","article-title":"Clozapine for movement disorder patients: A retrospective analysis of 38 patients","volume":"32","author":"Friedman","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB52","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0404.1994.tb01677.x","article-title":"Clozapine in the treatment of tremor in Parkinson's disease","volume":"89","author":"Jansen","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0404.1988.tb03668.x","article-title":"Clozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's disease","volume":"78","author":"Ostergaard","year":"1988","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 1","key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB54","first-page":"101","article-title":"Analysis of the mechanism of action of clozapine in Parkinson's disease","volume":"7","author":"Gershanik","year":"1992","journal-title":"Mov Disord"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/WNL.45.3.432","article-title":"Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease","volume":"45","author":"Rabey","year":"1995","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB56","first-page":"138","article-title":"Clozapine in the treatment of psychosis in Parkinsonism","volume":"242","author":"Rui Silva","year":"1995","journal-title":"J Neurol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB57","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/WNL.43.8.1551","article-title":"Suppression of dyskinesias in advanced Parkinson's disease. II. Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptoms","volume":"43","author":"Bennett","year":"1993","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB58","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/mds.870090406","article-title":"Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dykinesia reduction","volume":"9","author":"Bennett","year":"1994","journal-title":"Mov Disord"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.870080317","article-title":"Modulatory effect of clozapine on levodopa response in Parkinson's disease: a preliminary study","volume":"8","author":"Arevalo","year":"1993","journal-title":"Mov Disord"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mds.870080209","article-title":"Nocturnal akathisia in Parkinson's disease: Treatment with clozapine","volume":"8","author":"Linazasoro","year":"1993","journal-title":"Mov Disord"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1192\/bjp.159.1.166a","article-title":"Amitriptyline in clozapine-induced sialorrhoea","volume":"159","author":"Copp","year":"1991","journal-title":"Br J Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004714-199202000-00026","article-title":"Clonidine treatment of clozapine-induced hypersalivation","volume":"12","author":"Grabowski","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB63","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(95)91713-6","article-title":"Pirenzepine for clozapine-induced hypersalivation","volume":"346","author":"Fritze","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB64","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0922-4106(94)90047-7","article-title":"Clozapine is a potent and selective muscarinic M-4 receptor antagonist","volume":"269","author":"Zorn","year":"1994","journal-title":"Eur J Pharmacol Mol Pharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1176\/ajp.135.1.99","article-title":"Clozapine plasma levels and convulsions","volume":"135","author":"Simpson","year":"1978","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB66","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/WNL.41.3.369","article-title":"Clozapine-related seizures","volume":"41","author":"Devinsky","year":"1991","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00002826-198904000-00001","article-title":"Clozapine: an antipsychotic agent in Parkinson's disease","volume":"12","author":"Wolters","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB68","first-page":"99","article-title":"A case of clozapine-induced neuroleptic malignant syndrome","volume":"52","author":"Miller","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB69","first-page":"102","article-title":"Neuroleptic malignant syndrome associated with clozapine use","volume":"52","author":"Anderson","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB70","first-page":"105","article-title":"Clozapine-induced neuroleptic syndrome","volume":"52","author":"DasGupta","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB72","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJM199009203231211","article-title":"Mandatory monitoring for side effect. The burdening of clozapine","volume":"323","author":"Salzmann","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB73","first-page":"851","article-title":"An investigation of some side effects in 47 psychotic patients during treatment with clozapine and discontinuing of the treatment","volume":"29","author":"Kirkegaard","year":"1979","journal-title":"Arzneim-Forsch Drug Res"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB74","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJM199203193261218","article-title":"Nonleukopenic neutropenia in a patient treated with clozapine","volume":"326","author":"Cates","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB75","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00004714-199410000-00013","article-title":"Neutropenia with clozapine and methazolamide","volume":"14","author":"Burke","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/j.1600-0404.1996.tb07075.x-BIB76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0163-8343(93)90042-M","article-title":"Clozapine-induced agranulocytosis and colony stimulating cytokines","volume":"15","author":"Ryabik","year":"1993","journal-title":"Gen Hosp Psychiatry"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1996.tb07075.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1996.tb07075.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:44:04Z","timestamp":1671540244000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1996.tb07075.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1996.tb07075.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,11]]}}}